May 25, 2024 22:03 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
INDIA bloc performing mujra for vote bank, says Prime Minister Narendra Modi launching a scathing attack on opposition parties | West Bengal, Odisha brace for impact of Cyclone Remal, check the latest update on landfall time | Take care of your country: Arvind Kejriwal snubs Pakistan leader's post on Lok Sabha polls | Bangladeshi MP Anwarul Azim was honey-trapped; killers were paid Rs. 5 cr for his gory murder: Cops | NIA arrests another key conspirator in Bengaluru Rameshwaram Cafe blast case
Eurofins Scientific to acquire Advinus Therapeutics, announces Tata Sons

Eurofins Scientific to acquire Advinus Therapeutics, announces Tata Sons

| | 20 Jul 2017, 10:41 pm
Mumbai/ Kolkata, July 20 (IBNS): Tata Sons, Tata Industries and Rallis India on Thursday announced that they, along with individual shareholders of Advinus Therapeutics (“Advinus”), have signed a definitive agreement with Eurofins Scientific (“Eurofins”) for Eurofins to acquire Advinus.

The transaction is expected to close in the next several weeks, subject to the fulfilment of customary closing conditions. Advinus’ expertise complements Eurofins contract research, development and manufacturing (CDMO) capabilities.

Advinus is a leading preclinical contract research company for Safety Assessment, CMC Services, DMPK and Analytical R&D Services.

With over 10 years of GLP compliance and certification, Advinus serves diverse industries such as Biotech, Pharmaceuticals, Biologics, Agrochemicals, Nutraceuticals and Cosmetics.

Advinus has submitted over 50 end-to-end investigational new drug applications (INDs) to global regulators such as the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), the Medicines and Healthcare products Regulatory Agency in the UK (MHRA) and Health Canada among others. Located in Bangalore, India, Advinus operates a state-of-the art 20,000 m2 facility.

KRS Jamwal, Chairman of Advinus and Executive Director of Tata Industries, said: “Advinus has developed significant promise under Tata parenting, and will now realise its full potential joining the Eurofins family of laboratories. We are confident that with access to Eurofins’ global network and technical competencies, Advinus will be able to rapidly expand its analytical portfolio and services to benefit all its existing and future clients.”

Rajiv Malik, Chief Executive Officer of Advinus, said: “Advinus has substantial capabilities that are in synergy with Eurofins and provide us with additional opportunities to grow the Company. We are very excited about becoming a part of the Eurofins family.”
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.